1 / 14

Rare Disease Genetic Testing Market

Increasing technological advancements, including NGS and microarray, are prominent factors responsible for the marketu2019s growth. Also, the existence of Rare Diseases Clinical Research Network (RDCRN), an NIH-funded research network of 23 active research groups focused on the diagnosis & treatment of disorders, is anticipated to impact the industry positively. Furthermore, the decline in sequencing prices has shifted the attention to testing rare diseases, which has influenced the adoption of NGS, resulting in the marketu2019s growth.

Ronald15
Télécharger la présentation

Rare Disease Genetic Testing Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rare Disease Genetic Testing Market Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9%

  2. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% “As per Polaris Market Research report, Rare Disease Genetic Testing Market is attending major innovations & transformations and is projected to reach $2,414.90 Million By 2030 | CAGR: 13.9% during the conjecture period 2021 to 2028.” The global Rare Disease Genetic Testing Market report scrutinizes the present situation and development prognosis of the market. The report offers a complete knowledge of key parameters such as market size, share and growth, trends, cost structure, and comprehensive and statistical data in the global Rare Disease Genetic Testing Market. Also, the market overview section of the report holds an in-depth analysis of current and future trends, analyzing the data on a historical basis and forecasted data till the year 2028. The report traces key market drivers, covering potentially lucrative opportunities and challenges as well as drivers, obstacles, issues, and risks. ➢Rare Disease Genetic Testing Market Report Scope: The global Rare Disease Genetic Testing Market is segmented By Disease Type, By Technology, By Specialty, By End-use, By Region. The research report analyzes the most important trends related to the different segments that help to explain the market. The report additionally surveys both developed & developing regions considered for global Rare Disease Genetic Testing Market research. The regional analysis engages readers with a comprehensive overview of various countries and regions to help players plan effective expansion strategies. The report outlines the noteworthy factors, such as driving factors and challenges, that will explain the market’s future growth. Also, it covers an exhaustive coverage of major industry drivers, restraints, and their impact on global Rare Disease Genetic Testing Market growth during the forecast period from 2021-2028. The market research assists in studying the key plans, initiatives, and strategies for the development of the market. - 2 -

  3. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% By Disease Type By Technology By Specialty By End-use By Region •Neurological •Next-Generation •Molecular •Research •North America (U.S., Canada) •Europe (France, Germany, UK, Disease Sequencing Genetic Laboratories •Immunological •Whole Exome Tests & Cros Italy, Netherlands, Spain, •Chromosomal •Hospitals •Whole Genome Disorders & Russia) •Hematology •Asia Pacific (Japan, China, Genetic Clinics •Array •Diagnostic Tests Diseases India, Malaysia, Indonesia. Technology •Biochemical, •Endocrine Laboratories South Korea) •PCR-based & •Latin America (Brazil, Mexico, Genetic Metabolism Testing Tests Diseases Argentina) •FISH •Cancer •Middle East & Africa (Saudi •Sanger •Musculoskeletal Arabia, UAE, Israel, South Sequencing Africa) Disorders •Karyotyping •Cardiovascular Disorders •Dermatology Disease •Others ➢COVID-19 Impact Analysis for Rare Disease Genetic Testing Market The market has also been affected by the recent COVID-19 pandemic and is expected to experience its long- term effects over the forecast period. Extensive evaluation of the effect of the COVID-19 pandemic is given to uncover the major issues and potential paths forward. The report merges the customer spending habits, business target, dynamics of current market forces, re-routing of the supply chain, and competitors in the global Rare Disease Genetic Testing Market as a thorough analysis. The report serves overall estimation, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Rare Disease Genetic Testing Market across different regions and how major players are building strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities ➢Regional Outlook In terms of geography, the region dominated the market with its higher revenue share contribution. The driving factors for this regional market growth include the current technological advancements in the - 3 -

  4. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% industry, growing economic stability, huge government investments, and rising awareness related to the benefits of the product/service. ➢Browse Detailed Research Report on Rare Disease Genetic Testing Market Analysis: https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market ➢Competitive Landscape The report completely profiles prominent market players or industrialists covering company profile, product specifications, production capacity/sales, revenue, price, and gross margin & sales. Here you will find a comprehensive analysis of the competitive landscape and detailed information on vendors and factors that will challenge the growth of major vendors. The section highlights key points such as regional segmentation, major investments, and details of historical, present, and projected revenues. the product portfolio, market explanation, and classification are indicated. According to Polaris Market Research, the leading players with a noteworthy dominance in the Rare Disease Genetic Testing Market include 3billion, Inc., Ambry Genetics, Artemis DNA, Arup Laboratories, Baylor Genetics, Centogene N.V., Color Genomics, Inc., Coopersurgical, Inc., Eurofins Scientific, Fulgent Genetics Inc., Genomenon, Health Network Laboratories, Invitae Corp., Laboratory Corporation of America Holdings, Macrogen, Inc., Myriad Genetics, Inc., Opko Health, Inc., Perkin Elmer, Inc., PreventionGenetics, Progenity, Inc., Quest Diagnostics Inc., Realm IDX, Inc., and Strand Life Sciences. Request for sample: https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing- market/request-for-sample Table of Contents 1.Introduction 1.1. Report Description 1.1.1. Objectives of the Study 1.1.2. Market Scope 1.1.3. Assumptions 1.2. Stakeholders 2.Executive Summary 2.1. Market Highlights 3.Research Methodology 3.1. Overview 3.1.1. Data Mining 3.2. Data Sources 3.2.1. Primary Sources 3.2.2. Secondary Sources 4.Global Rare Disease Genetic Testing Market Insights - 4 -

  5. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% 4.1. Rare Disease Genetic Testing – Industry Snapshot 4.2. Rare Disease Genetic Testing Market Dynamics 4.2.1. Drivers and Opportunities 4.2.1.1. Expanding patient registry for rare disease 4.2.1.2. Government & Regulatory Support For Rare Disease Diagnosis 4.2.2. Restraints and Challenges 4.2.2.1. Limited Awareness about The Rare Disease Conditions 4.3.Porter’s Five Forces Analysis 4.3.1. Bargaining Power of Suppliers (Moderate) 4.3.2. Threats of New Entrants: (Low) 4.3.3. Bargaining Power of Buyers (Moderate) 4.3.4. Threat of Substitute (Moderate) 4.3.5. Rivalry among existing firms (High) 4.4. PESTLE Analysis 4.5. Rare Disease Genetic Testing Industry Trends 4.6.Value Chain Analysis 4.7. COVID-19 Impact Analysis 5.Global Rare Disease Genetic Testing Market, by Technology 5.1. Key Findings 5.2. Introduction 5.2.1. Global Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 5.3.Next-Generation Sequencing 5.3.1. Global Rare Disease Genetic Testing Market, by Next-Generation Sequencing, by Region, 2018 - 2030 (USD Million) 5.3.2.Whole Exome 5.3.2.1. Global Rare Disease Genetic Testing Market, by Whole Exome, by Region, 2018 - 2030 (USD Million) 5.3.3.Whole Genome 5.3.3.1. Global Rare Disease Genetic Testing Market, by Whole Genome, by Region, 2018 - 2030 (USD Million) 5.4.Array Technology 5.4.1. Global Rare Disease Genetic Testing Market, by Array Technology, by Region, 2018 - 2030 (USD Million) 5.5.PCR-based Testing 5.5.1. Global Rare Disease Genetic Testing Market, by PCR-based Testing, by Region, 2018 - 2030 (USD Million) 5.6.FISH 5.6.1. Global Rare Disease Genetic Testing Market, by FISH, by Region, 2018 - 2030 (USD Million) 5.7.Sanger Sequencing 5.7.1. Global Rare Disease Genetic Testing Market, by Sanger Sequencing, by Region, 2018 - 2030 (USD Million) 5.8.Karyotyping 5.8.1. Global Rare Disease Genetic Testing Market, by Karyotyping, by Region, 2018 - 2030 (USD Million) 6.Global Rare Disease Genetic Testing Market, by Specialty 6.1. Key Findings 6.2. Introduction 6.2.1. Global Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) - 5 -

  6. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% 6.3. Molecular Genetic Tests 6.3.1. Global Rare Disease Genetic Testing Market, by Molecular Genetic Tests, by Region, 2018 - 2030 (USD Million) 6.4.Chromosomal Genetic Tests 6.4.1. Global Rare Disease Genetic Testing Market, by Chromosomal Genetic Tests, by Region, 2018 - 2030 (USD Million) 6.5.Biochemical, Genetic Tests 6.5.1. Global Rare Disease Genetic Testing Market, by Biochemical, Genetic Tests, by Region, 2018 - 2030 (USD Million) 7.Global Rare Disease Genetic Testing Market, by Disease Type 7.1. Key Findings 7.2. Introduction 7.2.1. Global Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 7.3.Neurological Disease 7.3.1. Global Rare Disease Genetic Testing Market, by Neurological Disease, by Region, 2018 - 2030 (USD Million) 7.4.Immunological Disorders 7.4.1. Global Rare Disease Genetic Testing Market, by Immunological Disorders, by Region, 2018 - 2030 (USD Million) 7.5.Hematology Diseases 7.5.1. Global Rare Disease Genetic Testing Market, by Hematology Diseases, by Region, 2018 - 2030 (USD Million) 7.6.Endocrine & Metabolism Diseases 7.6.1. Global Rare Disease Genetic Testing Market, by Endocrine & Metabolism Diseases, by Region, 2018 - 2030 (USD Million) 7.7.Cancer 7.7.1. Global Rare Disease Genetic Testing Market, by Cancer, by Region, 2018 - 2030 (USD Million) 7.8.Musculoskeletal Disorders 7.8.1. Global Rare Disease Genetic Testing Market, by Musculoskeletal Disorders, by Region, 2018 - 2030 (USD Million) 7.9.Cardiovascular Disorders 7.9.1. Global Rare Disease Genetic Testing Market, by Cardiovascular Disorders, by Region, 2018 - 2030 (USD Million) 7.10. Dermatology Disease 7.10.1. Global Rare Disease Genetic Testing Market, by Dermatology Disease, by Region, 2018 - 2030 (USD Million) 7.11. Others 7.11.1. Global Other Rare Disease Genetic Testing Market, by Region, 2018 - 2030 (USD Million) 8.Global Rare Disease Genetic Testing Market, by End-use 8.1. Key Findings 8.2. Introduction 8.2.1. Global Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 8.3.Research Laboratories & Cros 8.3.1. Global Rare Disease Genetic Testing Market, by Research Laboratories & Cros, by Region, 2018 - 2030 (USD Million) 8.4.Hospitals & Clinics - 6 -

  7. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% 8.4.1. Global Rare Disease Genetic Testing Market, by Hospitals & Clinics, by Region, 2018 - 2030 (USD Million) 8.5.Diagnostic Laboratories 8.5.1. Global Rare Disease Genetic Testing Market, by Diagnostic Laboratories, by Region, 2018 - 2030 (USD Million) 9.Global Rare Disease Genetic Testing Market, by Geography 9.1. Key findings 9.2. Introduction 9.2.1. Rare Disease Genetic Testing Market Assessment, By Geography, 2018 - 2030 (USD Million) 9.3. Rare Disease Genetic Testing Market – North America 9.3.1. North America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.3.2. North America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.3.3. North America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.3.4. North America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.3.5. Rare Disease Genetic Testing Market – U.S. 9.3.5.1. U.S.: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.3.5.2. U.S.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.3.5.3. U.S.: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.3.5.4. U.S.: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.3.6. Rare Disease Genetic Testing Market – Canada 9.3.6.1. Canada: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.3.6.2. Canada: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.3.6.3. Canada: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.3.6.4. Canada: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.4. Rare Disease Genetic Testing Market – Europe 9.4.1. Europe: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.4.2. Europe: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.4.3. Europe: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.4.4. Europe: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.4.5. Rare Disease Genetic Testing Market – UK 9.4.5.1. UK: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.4.5.2. UK: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) - 7 -

  8. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% UK: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.4.5.4. UK: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.4.6. Rare Disease Genetic Testing Market – France 9.4.6.1. France: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.4.6.2. France: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.4.6.3. France: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.4.6.4. France: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.4.7. Rare Disease Genetic Testing Market – Germany 9.4.7.1. Germany: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.4.7.2. Germany: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.4.7.3. Germany: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.4.7.4. Germany: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.4.8. Rare Disease Genetic Testing Market – Italy 9.4.8.1. Italy: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.4.8.2. Italy: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.4.8.3. Italy: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.4.8.4. Italy: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.4.9. Rare Disease Genetic Testing Market – Spain 9.4.9.1. Spain: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.4.9.2. Spain: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.4.9.3. Spain: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.4.9.4. Spain: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.4.10. Rare Disease Genetic Testing Market – Netherlands 9.4.10.1. Netherlands: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.4.10.2. Netherlands: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.4.10.3. Netherlands: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.4.10.4. Netherlands: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.4.11. Rare Disease Genetic Testing Market – Russia 9.4.11.1. Russia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.4.5.3. - 8 -

  9. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% 9.4.11.2. Russia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.4.11.3. Russia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.4.11.4. Russia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.5. Rare Disease Genetic Testing Market – Asia Pacific 9.5.1. Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.5.2. Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.5.3. Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.5.4. Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.5.5. Rare Disease Genetic Testing Market – China 9.5.5.1. China: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.5.5.2. China.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.5.5.3. China: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.5.5.4. China: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.5.6. Rare Disease Genetic Testing Market – India 9.5.6.1. India: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.5.6.2. India.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.5.6.3. India: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.5.6.4. India: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.5.7. Rare Disease Genetic Testing Market – Japan 9.5.7.1. Japan: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.5.7.2. Japan.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.5.7.3. Japan: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.5.7.4. Japan: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.5.8. Rare Disease Genetic Testing Market – Malaysia 9.5.8.1. Malaysia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.5.8.2. Malaysia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.5.8.3. Malaysia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.5.8.4. Malaysia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.5.9. Rare Disease Genetic Testing Market – Indonesia - 9 -

  10. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% Indonesia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.5.9.2. Indonesia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.5.9.3. Indonesia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.5.9.4. Indonesia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.5.10. Rare Disease Genetic Testing Market – South Korea 9.5.10.1. South Korea: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.5.10.2. South Korea.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.5.10.3. South Korea: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.5.10.4. South Korea: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.6. Rare Disease Genetic Testing Market – Middle East & Africa 9.6.1. Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.6.2. Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.6.3. Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.6.4. Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.6.5. Rare Disease Genetic Testing Market – Saudi Arabia 9.6.5.1. Saudi Arabia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.6.5.2. Saudi Arabia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.6.5.3. Saudi Arabia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.6.5.4. Saudi Arabia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.6.6. Rare Disease Genetic Testing Market – South Africa 9.6.6.1. South Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.6.6.2. South Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.6.6.3. South Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.6.6.4. South Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.6.7. Rare Disease Genetic Testing Market – Israel 9.6.7.1. Israel: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.6.7.2. Israel: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.6.7.3. Israel: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.5.9.1. - 10 -

  11. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% Israel: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.6.8. Rare Disease Genetic Testing Market – UAE 9.6.8.1. UAE: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.6.8.2. UAE: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.6.8.3. UAE: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.6.8.4. UAE: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.7. Rare Disease Genetic Testing Market – Latin America 9.7.1. Latin America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.7.2. Latin America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.7.3. Latin America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.7.4. Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.7.5. Rare Disease Genetic Testing Market – Mexico 9.7.5.1. Mexico: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.7.5.2. Mexico: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.7.5.3. Mexico: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.7.5.4. Mexico: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.7.6. Rare Disease Genetic Testing Market – Brazil 9.7.6.1. Brazil: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.7.6.2. Brazil: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.7.6.3. Brazil: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.7.6.4. Brazil: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 9.7.7. Rare Disease Genetic Testing Market – Argentina 9.7.7.1. Argentina: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million) 9.7.7.2. Argentina: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million) 9.7.7.3. Argentina: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million) 9.7.7.4. Argentina: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million) 10.Competitive Landscape 10.1. Expansion and Acquisition Analysis 10.1.1. Expansion 10.1.2. Acquisitions 10.2. Partnerships/Collaborations/Agreements/Exhibitions 9.6.7.4. - 11 -

  12. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% 11.Company Profiles 11.1. 11.1.1. Company Overview 11.1.2. Financial Performance 11.1.3. Product Benchmarking 11.1.4. Recent Development 11.2. Ambry Genetics 11.2.1. Company Overview 11.2.2. Financial Performance 11.2.3. Product Benchmarking 11.2.4. Recent Development 11.3. Artemis DNA 11.3.1. Company Overview 11.3.2. Financial Performance 11.3.3. Product Benchmarking 11.3.4. Recent Development 11.4. Arup Laboratories 11.4.1. Company Overview 11.4.2. Financial Performance 11.4.3. Product Benchmarking 11.4.4. Recent Development 11.5. Baylor Genetics 11.5.1. Company Overview 11.5.2. Financial Performance 11.5.3. Product Benchmarking 11.5.4. Recent Development 11.6. Centogene N.V 11.6.1. Company Overview 11.6.2. Financial Performance 11.6.3. Product Benchmarking 11.6.4. Recent Development 11.7. Color Genomics, Inc 11.7.1. Company Overview 11.7.2. Financial Performance 11.7.3. Product Benchmarking 11.7.4. Recent Development 11.8. Coopersurgical, Inc 11.8.1. Company Overview 11.8.2. Financial Performance 11.8.3. Product Benchmarking 11.8.4. Recent Development 11.9. Eurofins Scientific 11.9.1. Company Overview 11.9.2. Financial Performance 11.9.3. Product Benchmarking 11.9.4. Recent Development 11.10. Fulgent Genetics Inc 11.10.1. 11.10.2. 11.10.3. 11.10.4. 3billion, Inc Company Overview Financial Performance Product Benchmarking Recent Development - 12 -

  13. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% 11.11. Genomenon 11.11.1. 11.11.2. 11.11.3. 11.11.4. 11.12. 11.12.1. 11.12.2. 11.12.3. 11.12.4. 11.13. 11.13.1. 11.13.2. 11.13.3. 11.13.4. 11.14. 11.14.1. 11.14.2. 11.14.3. 11.14.4. 11.15. 11.15.1. 11.15.2. 11.15.3. 11.15.4. 11.16. 11.16.1. 11.16.2. 11.16.3. 11.16.4. 11.17. 11.17.1. 11.17.2. 11.17.3. 11.17.4. 11.18. 11.18.1. 11.18.2. 11.18.3. 11.18.4. 11.19. 11.19.1. 11.19.2. 11.19.3. 11.19.4. 11.20. 11.20.1. 11.20.2. 11.20.3. 11.20.4. 11.21. Company Overview Financial Performance Product Benchmarking Recent Development Health Network Laboratories Company Overview Financial Performance Product Benchmarking Recent Development Invitae Corp Company Overview Financial Performance Product Benchmarking Recent Development Laboratory Corporation of America Holdings Company Overview Financial Performance Product Benchmarking Recent Development Macrogen, Inc Company Overview Financial Performance Product Benchmarking Recent Development Myriad Genetics, Inc. Company Overview Financial Performance Product Benchmarking Recent Development Opko Health, Inc Company Overview Financial Performance Product Benchmarking Recent Development Perkin Elmer, Inc Company Overview Financial Performance Product Benchmarking Recent Development PreventionGenetics Company Overview Financial Performance Product Benchmarking Recent Development Progenity, Inc Company Overview Financial Performance Product Benchmarking Recent Development Quest Diagnostics Inc. - 13 -

  14. Rare Disease Genetic Testing Market Size Worth $2,414.90 Million By 2030 | CAGR: 13.9% 11.21.1. 11.21.2. 11.21.3. 11.21.4. 11.22. 11.22.1. 11.22.2. 11.22.3. 11.22.4. 11.23. 11.23.1. 11.23.2. 11.23.3. 11.23.4. Company Overview Financial Performance Product Benchmarking Recent Development Realm IDX, Inc Company Overview Financial Performance Product Benchmarking Recent Development Strand Life Sciences. Company Overview Financial Performance Product Benchmarking Recent Development ➢Access Press Release on Rare Disease Genetic Testing Market: https://www.polarismarketresearch.com/press-releases/healthcare-patent-filing-outsourcing-market ➢About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 14 -

More Related